Brody Wehman1, Kristen A Stafford2, Gregory J Bittle1, Zachary N Kon1, Charles F Evans1, Keshava Rajagopal1, Nicholas Pietris3, Sunjay Kaushal1, Bartley P Griffith4. 1. Division of Cardiac Surgery, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland. 2. Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland. 3. Division of Pediatric Cardiology, Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland. 4. Division of Cardiac Surgery, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland. Electronic address: bgriffith@smail.umaryland.edu.
Abstract
BACKGROUND: Pediatric patients awaiting orthotopic heart transplantation frequently require bridge to transplantation (BTT) with mechanical circulatory support. Posttransplant survival outcomes and predictors of mortality have not been thoroughly described in the modern era using a large-scale analysis. METHODS: The United Network for Organ Sharing database was reviewed to identify pediatric heart transplant recipients from 2005 through 2012. Patients were stratified into three groups: extracorporeal membrane oxygenation (ECMO), ventricular assist device (VAD), and direct transplantation (DTXP). The primary outcome was posttransplant survival. RESULTS: Two thousand seven hundred seventy-seven pediatric patients underwent orthotopic heart transplantation. There were 617 patients who required BTT with mechanical circulatory support (22.2%), of whom there were 428 VAD BTT (69.4%) and 189 ECMO BTT (30.6%). An increase in VAD use was observed during the study period (p < 0.0001). Compared with DTXP, patients in the ECMO BTT group had a lower median age (<1 versus 5 years; p < 0.0001) and were significantly smaller (8 versus 14 kg; p < 0.001), whereas patients in the VAD BTT group were older (8 versus 5 years; p = 0.0002) and larger (24 versus 14 kg; p < 0.001). Actuarial survival was greater in the DTXP group compared with ECMO BTT, but similar to VAD BTT at 30 days and 1, 3, and 5 years. However, this survival difference was lost after censoring the first 4 months after transplant. In multivariable analysis, when restricted to the first 4 months of survival, independent predictors for mortality were ECMO BTT, age, diagnosis, and functional status, whereas VAD BTT was not. CONCLUSIONS: Pediatric patients with DTXP or VAD BTT have equivalent posttransplant survival. However, those requiring ECMO BTT have inferior early posttransplant survival compared with those receiving DTXP.
BACKGROUND: Pediatric patients awaiting orthotopic heart transplantation frequently require bridge to transplantation (BTT) with mechanical circulatory support. Posttransplant survival outcomes and predictors of mortality have not been thoroughly described in the modern era using a large-scale analysis. METHODS: The United Network for Organ Sharing database was reviewed to identify pediatric heart transplant recipients from 2005 through 2012. Patients were stratified into three groups: extracorporeal membrane oxygenation (ECMO), ventricular assist device (VAD), and direct transplantation (DTXP). The primary outcome was posttransplant survival. RESULTS: Two thousand seven hundred seventy-seven pediatric patients underwent orthotopic heart transplantation. There were 617 patients who required BTT with mechanical circulatory support (22.2%), of whom there were 428 VAD BTT (69.4%) and 189 ECMO BTT (30.6%). An increase in VAD use was observed during the study period (p < 0.0001). Compared with DTXP, patients in the ECMO BTT group had a lower median age (<1 versus 5 years; p < 0.0001) and were significantly smaller (8 versus 14 kg; p < 0.001), whereas patients in the VAD BTT group were older (8 versus 5 years; p = 0.0002) and larger (24 versus 14 kg; p < 0.001). Actuarial survival was greater in the DTXP group compared with ECMO BTT, but similar to VAD BTT at 30 days and 1, 3, and 5 years. However, this survival difference was lost after censoring the first 4 months after transplant. In multivariable analysis, when restricted to the first 4 months of survival, independent predictors for mortality were ECMO BTT, age, diagnosis, and functional status, whereas VAD BTT was not. CONCLUSIONS: Pediatric patients with DTXP or VAD BTT have equivalent posttransplant survival. However, those requiring ECMO BTT have inferior early posttransplant survival compared with those receiving DTXP.
Authors: Jonathan M Chen; Marc E Richmond; Kevin Charette; Hiroo Takayama; Mathew Williams; Lisa Gilmore; Alejandro Garcia; Linda J Addonizio Journal: J Thorac Cardiovasc Surg Date: 2011-12-03 Impact factor: 5.209
Authors: Anne I Dipchand; Richard Kirk; Leah B Edwards; Anna Y Kucheryavaya; Christian Benden; Jason D Christie; Fabienne Dobbels; Lars H Lund; Axel O Rahmel; Roger D Yusen; Josef Stehlik Journal: J Heart Lung Transplant Date: 2013-10 Impact factor: 10.247
Authors: S Kaushal; K L Matthews; X Garcia; B Wehman; E Riddle; Z Ying; R Nubani; C E Canter; W R Morrow; C B Huddleston; C L Backer; E Pahl Journal: Pediatr Transplant Date: 2013-11-07
Authors: David L S Morales; Christopher S D Almond; Robert D B Jaquiss; David N Rosenthal; David C Naftel; M Patricia Massicotte; Tilman Humpl; Mark W Turrentine; James S Tweddell; Gordon A Cohen; Robert Kroslowitz; Eric J Devaney; Charles E Canter; Francis Fynn-Thompson; Olaf Reinhartz; Michiaki Imamura; Nancy S Ghanayem; Holger Buchholz; Sarah Furness; Robert Mazor; Sanjiv K Gandhi; Charles D Fraser Journal: J Heart Lung Transplant Date: 2011-01 Impact factor: 10.247
Authors: Carl A Johnson; Peter D Wearden; Ergin Kocyildirim; Timothy M Maul; Joshua R Woolley; Sang-Ho Ye; Elise M Strickler; Harvey S Borovetz; William R Wagner Journal: Artif Organs Date: 2011-04-05 Impact factor: 3.094
Authors: Eva Maria Delmo Walter; Vladimir Alexi-Meskishvili; Michael Huebler; Antonino Loforte; Brigitte Stiller; Yuguo Weng; Wolfgang Boettcher; Felix Berger; Roland Hetzer Journal: Interact Cardiovasc Thorac Surg Date: 2010-02-05
Authors: Douglas Mah; Tajinder P Singh; Ravi R Thiagarajan; Kimberlee Gauvreau; Gary E Piercey; Elizabeth D Blume; Francis Fynn-Thompson; Christopher S D Almond Journal: J Heart Lung Transplant Date: 2009-09-26 Impact factor: 10.247
Authors: Ryan R Davies; Mark J Russo; Kimberly N Hong; Michael L O'Byrne; David P Cork; Alan J Moskowitz; Annetine C Gelijns; Seema Mital; Ralph S Mosca; Jonathan M Chen Journal: J Thorac Cardiovasc Surg Date: 2008-02 Impact factor: 5.209
Authors: Alex Hsieh; Dmitry Tumin; Patrick I McConnell; Mark Galantowicz; Joseph D Tobias; Don Hayes Journal: Pediatr Cardiol Date: 2016-11-24 Impact factor: 1.655
Authors: David M Peng; Devin A Koehl; Ryan S Cantor; Kristen N McMillan; Aliessa P Barnes; Patrick I McConnell; Jessica Jordan; Nicholas D Andersen; James D St Louis; Katsuhide Maeda; James K Kirklin; Steven J Kindel Journal: J Heart Lung Transplant Date: 2018-10-31 Impact factor: 10.247
Authors: Leonardo A Miana; Guilherme Viotto Rodrigues da Silva; Luiz Fernando Caneo; Aida Luisa Turquetto; Carla Tanamati; Gustavo Foronda; Maria Raquel Massoti; Juliano G Penha; Estela Azeka; Filomena R B G Galas; Fabio B Jatene; Marcelo B Jatene Journal: Braz J Cardiovasc Surg Date: 2018 May-Jun